Stay updated on Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page.

Latest updates to the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedA new PubMed publication citation by Weidinger et al. was added to the Publications section for the study. The page version was updated from v3.6.2 to v3.6.3.SummaryDifference0.0%

- Check17 days agoChange DetectedThe page's revision tag advanced from v3.6.0 to v3.6.2, signaling a minor update to the page's documentation. The change does not modify trial content or functionality.SummaryDifference0.0%

- Check31 days agoChange DetectedRecruitment status updated to 'No longer looking for participants' and new help sections were added (How to Read a Study Record, Common Questions, How to Join a Study). The page introduces an Intervention/Treatment section header while removing the previous Intervention / Treatment header, and the site revision version updated to v3.6.0.SummaryDifference0.2%

- Check39 days agoChange DetectedThe revision tag on the page was updated from Revision: v3.5.4 to Revision: v3.5.5. This indicates a newer page version.SummaryDifference0.0%

- Check53 days agoChange DetectedAdded a new publication reference about variable-dose versus continuous-dose abrocitinib in moderate-to-severe atopic dermatitis to the Publications section. This expands the study's literature context for readers.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4. This reflects a minor update to the page's underlying software or documentation rather than changes to the visible study details.SummaryDifference0.0%

Stay in the know with updates to Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page.